HK1207664A1 - Biomarkers for diabetes and usages thereof - Google Patents

Biomarkers for diabetes and usages thereof

Info

Publication number
HK1207664A1
HK1207664A1 HK15108232.4A HK15108232A HK1207664A1 HK 1207664 A1 HK1207664 A1 HK 1207664A1 HK 15108232 A HK15108232 A HK 15108232A HK 1207664 A1 HK1207664 A1 HK 1207664A1
Authority
HK
Hong Kong
Prior art keywords
usages
biomarkers
diabetes
Prior art date
Application number
HK15108232.4A
Other languages
English (en)
Chinese (zh)
Inventor
李勝輝
馮强
揭著業
張東亞
覃俊杰
王俊
汪建
楊煥明
Original Assignee
Bgi Shenzhen
Bgi Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bgi Shenzhen, Bgi Shenzhen Co Ltd filed Critical Bgi Shenzhen
Publication of HK1207664A1 publication Critical patent/HK1207664A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
HK15108232.4A 2012-08-01 2015-08-25 Biomarkers for diabetes and usages thereof HK1207664A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2012079497 2012-08-01
PCT/CN2013/076799 WO2014019408A1 (en) 2012-08-01 2013-06-05 Biomarkers for diabetes and usages thereof

Publications (1)

Publication Number Publication Date
HK1207664A1 true HK1207664A1 (en) 2016-02-05

Family

ID=50027204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108232.4A HK1207664A1 (en) 2012-08-01 2015-08-25 Biomarkers for diabetes and usages thereof

Country Status (3)

Country Link
US (1) US10100360B2 (xx)
HK (1) HK1207664A1 (xx)
WO (1) WO2014019408A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015018308A1 (en) * 2013-08-06 2015-02-12 BGI Shenzhen Co.,Limited Biomarkers for colorectal cancer
WO2016008082A1 (en) * 2014-07-15 2016-01-21 Zhejiang University Gene marker for liver cirrhosis and usages thereof
DK3250676T3 (da) * 2015-01-30 2021-09-06 Bgi Shenzhen Biomarkører for kolorektal cancer-relaterede sygdomme
CN105296620B (zh) * 2015-10-26 2019-01-15 上海市内分泌代谢病研究所 肠道宏基因组特征作为2型糖尿病阿卡波糖疗效筛选标志

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101591738B1 (ko) * 2007-11-13 2016-02-04 베리덱스, 엘엘씨 당뇨병의 진단 생체마커

Also Published As

Publication number Publication date
WO2014019408A1 (en) 2014-02-06
US20150292011A1 (en) 2015-10-15
US10100360B2 (en) 2018-10-16

Similar Documents

Publication Publication Date Title
HK1207122A1 (en) Biomarkers for diabetes and usages thereof
HK1218329A1 (zh) 型糖尿病生物標誌物及其用途
HK1205764A1 (en) Tuberculosis biomarkers and uses thereof
GB201213567D0 (en) Biomarkers
GB201218933D0 (en) An entity
IL234234B (en) 2ang binding molecules
GB201211982D0 (en) Biomarker
ZA201409006B (en) Diabetes biomarkers
EP2861623A4 (en) NEW SPECIFIC CLEC14A ANTIBODY AND USES THEREOF
EP2897614A4 (en) CMPF ACID AS A BIOMARKER FOR DIABETES AND ASSOCIATED METHODS
EP2819749A4 (en) BIOMARKERS ASSOCIATED WITH AUTISM AND USES THEREOF
GB201213163D0 (en) Photopolymerisation processes and novel compounds therefor
EP2828282A4 (en) BIOMARKERS
HK1202899A1 (en) Biomarkers for diabetes
GB201211158D0 (en) Biomarkers and uses thereof
GB201210565D0 (en) Biomarkers
HK1207664A1 (en) Biomarkers for diabetes and usages thereof
PL2626134T3 (pl) Pipeta
EP2889504A4 (en) IRREVERSIBLE MECHANISM
PL2882708T3 (pl) Nowe związki i ich zastosowania
EP2864782A4 (en) BIOMARKERS OF DEMENTIA WITH NEUROFIBRILLARY DEGENERATION
GB201209802D0 (en) Biomarker
GB201202944D0 (en) Biomarker
EP2804845A4 (en) LITHIUM ION CONDUCTIVE MATERIALS
EP2810427A4 (en) CHARACTER SET FOR PRINTING PATTERNS